These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 26324841)
1. Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan. Jingu K; Umezawa R; Matsushita H; Sugawara T; Kubozono M; Yamamoto T; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Kadoya N; Takeda K Int J Clin Oncol; 2016 Apr; 21(2):276-282. PubMed ID: 26324841 [TBL] [Abstract][Full Text] [Related]
2. FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer. Jingu K; Umezawa R; Yamamoto T; Takeda K; Ishikawa Y; Takahashi N; Kadoya N; Matsushita H Int J Clin Oncol; 2019 Aug; 24(8):927-933. PubMed ID: 30863993 [TBL] [Abstract][Full Text] [Related]
3. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer. Zenda S; Hironaka S; Boku N; Yamazaki K; Yasui H; Fukutomi A; Yoshino T; Onozawa Y; Nishimura T Dis Esophagus; 2008; 21(3):195-200. PubMed ID: 18430098 [TBL] [Abstract][Full Text] [Related]
4. Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2). Higuchi K; Komori S; Tanabe S; Katada C; Azuma M; Ishiyama H; Sasaki T; Ishido K; Katada N; Hayakawa K; Koizumi W; Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):872-9. PubMed ID: 24867539 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of radiochemotherapy for solitary lymph node metastasis after curative resection of esophageal cancer. Jingu K; Ariga H; Nemoto K; Narazaki K; Umezawa R; Takeda K; Koto M; Sugawara T; Kubozono M; Miyata G; Onodera K; Yamada S Int J Radiat Oncol Biol Phys; 2012 May; 83(1):172-7. PubMed ID: 22079727 [TBL] [Abstract][Full Text] [Related]
6. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer. de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy. Ito T; Kaneko K; Makino R; Ito H; Konishi K; Kurahashi T; Kitahara T; Mitamura K J Gastroenterol; 2001 May; 36(5):303-11. PubMed ID: 11388392 [TBL] [Abstract][Full Text] [Related]
8. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery. Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion. Yamaguchi S; Morita M; Yamamoto M; Egashira A; Kawano H; Kinjo N; Tsujita E; Minami K; Ikebe M; Ikeda Y; Kunitake N; Toh Y Ann Surg Oncol; 2018 Oct; 25(11):3280-3287. PubMed ID: 30051363 [TBL] [Abstract][Full Text] [Related]
11. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. Ohtsu A; Boku N; Muro K; Chin K; Muto M; Yoshida S; Satake M; Ishikura S; Ogino T; Miyata Y; Seki S; Kaneko K; Nakamura A J Clin Oncol; 1999 Sep; 17(9):2915-21. PubMed ID: 10561371 [TBL] [Abstract][Full Text] [Related]
12. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma. Chen J; Pan J; Liu J; Li J; Zhu K; Zheng X; Chen M; Chen M; Liao Z Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):671-7. PubMed ID: 23773390 [TBL] [Abstract][Full Text] [Related]
13. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Kaneko K; Ito H; Konishi K; Kurahashi T; Ito T; Katagiri A; Yamamoto T; Kitahara T; Mizutani Y; Ohtsu A; Mitamura K Br J Cancer; 2003 Jan; 88(1):18-24. PubMed ID: 12556953 [TBL] [Abstract][Full Text] [Related]
14. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy. Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176 [TBL] [Abstract][Full Text] [Related]
15. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis. Xu HY; Wu SX; Luo HS; Chen CY; Lin LX; Huang HC Radiat Oncol; 2018 Oct; 13(1):200. PubMed ID: 30326912 [TBL] [Abstract][Full Text] [Related]
16. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma. Ochi M; Murakami Y; Nishibuchi I; Kubo K; Imano N; Takeuchi Y; Kimura T; Hamai Y; Emi M; Okada M; Nagata Y J Radiat Res; 2021 Jan; 62(1):142-148. PubMed ID: 33392619 [TBL] [Abstract][Full Text] [Related]
17. Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy. Sakanaka K; Ishida Y; Itasaka S; Ezoe Y; Aoyama I; Miyamoto S; Horimatsu T; Muto M; Hiraoka M Int J Clin Oncol; 2016 Oct; 21(5):899-908. PubMed ID: 26936851 [TBL] [Abstract][Full Text] [Related]
18. Results of chemoradiotherapy for stage I esophageal cancer in medically inoperable patients compared with results in operable patients. Jingu K; Matsushita H; Takeda K; Narazaki K; Ariga H; Umezawa R; Sugawara T; Miyata G; Onodera K; Nemoto K; Yamada S Dis Esophagus; 2013 Jul; 26(5):522-7. PubMed ID: 22925398 [TBL] [Abstract][Full Text] [Related]
19. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma. Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687 [TBL] [Abstract][Full Text] [Related]
20. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer. Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]